Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LEDA: Effect of Aspirin on Renal Disease Progression in Patients with Type 2 Diabetes
2015-005231-40Phase 3Active
- Sponsor
- Azienda Ospedaliero-Universitaria Policlinico Umberto I
- Start
- Nov 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of aspirin in type 2 diabetes mellitus (T2DM), diabetic glomerulosclerosis, sponsored by Azienda Ospedaliero-Universitaria Policlinico Umberto I. Started Nov 2020; status: active.
02
Drugs
aspirin
03
Conditions
type 2 diabetes mellitus (T2DM)diabetic glomerulosclerosis
Beyond the preview
Go deeper on 2015-005231-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-005231-40.